Patent Application for Reducing Blood Glucose with Plants
Summary
The USPTO has published a new patent application (US20260083803A1) detailing methods and compositions for reducing fasting blood glucose in mammals using plants like Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.
What changed
This document is a publication of a patent application filed with the USPTO, specifically application number 18898639, titled "METHODS AND COMPOSITIONS FOR REDUCING FASTING BLOOD GLUCOSE IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES." The application, filed on September 26, 2024, describes the use of Dichrostachys glomerata or Cissus quadrangularis to potentially increase GLP-1 levels and reduce blood glucose, visceral fat, cholesterol, and food intake. The inventors listed are Shil Kothari and Julius Enyoug Oben.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future developments in therapeutic approaches for managing blood glucose levels. Companies involved in pharmaceutical development, nutraceuticals, or health supplements may find the disclosed methods and compositions of interest for research and development purposes. The application is scheduled for publication on March 26, 2026.
Source document (simplified)
METHODS AND COMPOSITIONS FOR REDUCING FASTING BLOOD GLUCOSE IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES
Application US20260083803A1 Kind: A1 Mar 26, 2026
Inventors
Shil Kothari, Julius Enyoug Oben
Abstract
Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing fasting blood glucose in a mammal is provided where the composition comprises an effective amount of Dichrostachys glomerata provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
CPC Classifications
A61K 36/48 A61P 3/10 A61K 2236/17 A61K 2236/33
Filing Date
2024-09-26
Application No.
18898639
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.